India’s Belzutifan 40mg Film-Coated Tablets for VHL-RCC

Belzutifan is a tiny drug that blocks something called HIF-2α, which is a big deal enzyme when cells need to handle low oxygen. It’s been okayed for treating a kidney cancer that’s linked to something called VHL syndrome. The way it works is by messin’ with how tumor cells talk when they’re low on oxygen, which helps shrink the tumors.

You’re supposed to take 120 mg of it every day, and it’s a pill you swallow. You get it in these 40 mg tablets covered with a film. A bottle holds 90 of them.

The goal of the treatment is to help people live longer and stop the cancer from getting worse.